Similarly, plasmatic or urinary metanephrines and the assessment of the plasma aldosterone/renin activity ratio are crucial to rule out the presence of pheochromocytoma and primary aldosteronism, respectively [12]. The gene discussed is REN; the disease is primary aldosteronism.